We’ve been active in the emerging regenerative medicine sector for a number of decades, supporting our clients in the development of novel therapeutic options and medical device systems. We have developed, represented and positioned a number of products from disposable delivery devices for use during surgery, to point of care systems that enable in vivo treatment in the private practice.
We are accustomed to working with early-stage companies with technologies and treatments in the regenerative medicine field. Our approach to understanding the target users and underlying technology means that we can deliver tangible solutions that meet commercial and usability requirements, or proof-of-principle concepts that enable testing and trials.